Personalis at Non-Small Cell Lung Cancer Drug Development (NSCLC) Summit: July 14-15, 2021

Presentation

July 14 – 15, 2021

Presentation Title: Advancing Biomarker Discovery: Enabling improved tumor immunogenomics through a comprehensive approach
Presenter: Travis Yates, PhD

This presentation will cover:

  • Predicting patient response to immunotherapies requires a robust and comprehensive approach to tumor immunogenomics.
  • By combining highly sensitive, exome-scale DNA and RNA sequencing with advanced analytics, ImmunoID NeXT™ provides a broad view of the tumor and the immune-related components of the tumor microenvironment from a single, limited sample.
  • Combination of ImmunoID NeXT and our exome-wide liquid biopsy assay, NeXT Liquid Biopsy, allows for increased exploration of critical areas of tumor biology.

Connect with us at Non-Small Cell Lung Cancer Drug Development (NSCLC) Summit 2021